MedTrace Logo

Imaging to Improve Brain Stimulation

NCT04016402 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 42

Last updated 2025-05-04

No results posted yet for this study

Summary

This study investigates how brains change as a result of a treatment for depression called repetitive transcranial magnetic stimulation (rTMS). People who receive rTMS will have pictures of their brains and brain activity taken by a magnetic resonance imaging (MRI) scanner before and after their treatment, as well as up to three times during the six-week treatment course. These images will be examined to see if the rTMS is placed correctly to help treat their symptoms, and what changes in brain activity are happening during the rTMS treatment

Conditions

  • Depressive Disorder

Interventions

DEVICE

Repetitive Transcranial Magnetic Stimulation (rTMS)

Clinical transcranial magnetic stimulation administered as part of usual care for the study population

Sponsors & Collaborators

  • VA Palo Alto Health Care System

    collaborator FED

  • Brown University

    collaborator OTHER

  • VA Office of Research and Development

    lead FED

Principal Investigators

  • Allyson C Rosen, PhD · VA Palo Alto Health Care System, Palo Alto, CA

  • Noah S. Philip, MD · Providence VA Medical Center, Providence, RI

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-24
Primary Completion
2024-09-30
Completion
2025-12-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04016402 on ClinicalTrials.gov